Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Trinity Biotech (TRIB) Raw Materials (2016 - 2020)

Historic Raw Materials for Trinity Biotech (TRIB) over the last 5 years, with Q4 2020 value amounting to $12.2 million.

  • Trinity Biotech's Raw Materials fell 384.07% to $12.2 million in Q4 2020 from the same period last year, while for Dec 2020 it was $12.2 million, marking a year-over-year decrease of 384.07%. This contributed to the annual value of $12.2 million for FY2020, which is 384.07% down from last year.
  • Latest data reveals that Trinity Biotech reported Raw Materials of $12.2 million as of Q4 2020, which was down 384.07% from $12.7 million recorded in Q4 2019.
  • Trinity Biotech's 5-year Raw Materials high stood at $12.7 million for Q4 2019, and its period low was $9.2 million during Q4 2016.
  • Moreover, its 5-year median value for Raw Materials was $10.6 million (2018), whereas its average is $11.0 million.
  • Its Raw Materials has fluctuated over the past 5 years, first soared by 1987.5% in 2019, then tumbled by 384.07% in 2020.
  • Trinity Biotech's Raw Materials (Quarter) stood at $9.2 million in 2016, then rose by 12.74% to $10.3 million in 2017, then increased by 2.04% to $10.6 million in 2018, then rose by 19.87% to $12.7 million in 2019, then decreased by 3.84% to $12.2 million in 2020.
  • Its Raw Materials stands at $12.2 million for Q4 2020, versus $12.7 million for Q4 2019 and $10.6 million for Q4 2018.